Joerg C. Schefold - Publications

Immunostimulation using granulocyte- and granulocyte-macrophage colony stimulating factor in patients with severe sepsis and septic shock.

Journal: Critical care (London, England)

Published: April 15, 2011

Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.

Journal: Scandinavian journal of infectious diseases

Published: December 05, 2009

Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis.

Journal: Blood purification

Published: June 10, 2009

Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 22, 2009

Dislocation of a metal stent to the right ventricle: an unusual finding in the heart.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: June 12, 2008

Sepsis: time has come to focus on the later stages.

Journal: Medical hypotheses

Published: February 28, 2008

Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements.

Journal: Clinical biochemistry

Published: December 28, 2007

Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report.

Journal: Journal of medical case reports

Published: September 22, 2007